Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Lost your password? Please enter your email address. You will receive a link and will create a new password via email.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
| Q.1 | फरवरी 2022 में देश में मिर्गी के इलाज के लिए नैटको फार्मा द्वारा ब्रेकिटा (BRECITA) ब्रांड के अंतर्गत लॉन्च की गई दवा कौन सी थी? | |
| Ans | A. एपिकारासेटम (Epicaracetam) | |
| B. लैमरासेटम (Lamaracetum) | ||
| C. ब्राइवेरासेटम (Brivaracetam) | ||
| D. नटरासेटम (Nataracetam) |
Correct Ans Provided: C
